Immunohistochemical (IHC) staining confirmed significant SLC44A2 upregulation in tumors from the SLC44A2-overexpressing group compared to the control group (Fig. S2E), indicating that SLC44A2 overexpression inhibited tumor growth. Here, SLC44A2 is linked to neoplasm.